Pharmaceutical enterprise
The full closed loop, governed for enterprise R&D.
Large pharmaceutical organisations run regulated, multi-region research across many teams. Veriomics gives them the whole closed loop, literature to decision, with organisation governance and provenance throughout, on a universally accessible commercial architecture where no region is privileged.
One auditable chain
Provenance across every team and site.
The same closed loop, governed: organisation workspaces, role-based access, and an unbroken evidential chain from the literature to the report.
At enterprise scale
Governance, provenance, and trust
Organisation governance
Workspaces and role governance across teams and sites, with the decision-support boundary surfaced consistently on every analytical output.
Full provenance, end to end
Every result traces through execution, planning, and validation to the literature consensus it began with. Exportable as reproducibility certificates aligned with PRISMA 2020, STROBE, and CONSORT.
Multi-region data residency
Operate across regulatory regions with data residency and no region privileged over another.
Transparent commercial terms
Published organisation pricing with quota-against-usage dashboards. No credits, tokens, or consumed units. Pre-flight cost estimates before any heavy-compute run.
No region privileged
Available across ten regulatory regions.
The platform is positioned as Decision Support Software on an equal footing across regions, no single-market-first framing.
Australia
TGA, Therapeutic Goods Administration
Canada
Health Canada,
European Union
EMA, European Medicines Agency
India
CDSCO, Central Drugs Standard Control Organisation
Japan
PMDA, Pharmaceuticals and Medical Devices Agency
Nordic countries
National medicines agencies,
Pakistan
DRAP, Drug Regulatory Authority of Pakistan
Singapore
HSA, Health Sciences Authority
United Kingdom
MHRA, Medicines and Healthcare products Regulatory Agency
United States
FDA, Food and Drug Administration, Decision Support Software classification